Evaluation of an extensively hydrolysed casein formula (Damira 2000®) in children with allergy to cow's milk proteins

The new extensively hydrolysed casein product is safe and well tolerated by most children with ACMP. However, as with other extensive hydrolysates, some highly sensitised patients may present clinical manifestations. Controlled tolerance testing is therefore advised, under specialised medical supervision.